财务
- Market Capitalization 2.68 B
- Employee 47
- Founded 1998
- CEO Helen Sabzevari
- Website www.precigen.com
- Headquarter Virginia, United States
- FIGI BBG000QL8VH9
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-3.05
市销率
135.09
相关股票代码
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1696 | RCUS Arcus Biosciences, Inc. Common Stock | 22.49 USD | -7.60% | -6.02% | -5.94% | +43.34% | 2.86 B USD | ||
| 1698 | DYN Dyne Therapeutics, Inc. - Common Stock | 15.30 USD | -4.14% | -0.65% | -17.39% | -34.64% | 2.86 B USD | ||
| 1769 | ZLAB Zai Lab Limited - American Depositary Shares | 23.10 USD | -6.06% | -8.33% | -5.68% | -13.45% | 2.59 B USD | ||
| 1792 | BEAM Beam Therapeutics Inc. - Common Stock | 24.43 USD | -2.79% | -0.85% | +2.56% | -4.79% | 2.52 B USD |